Cargando…
Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells
To enhance the anticancer efficacy of gemcitabine in the treatment of non-small cell lung cancer (NSCLC), the potential synergistic effect of piceatannol on gemcitabine cytotoxicity was investigated in the human NSCLC A459 cell line. The MTT cell viability assay showed that piceatannol significantly...
Autores principales: | Xu, Bin, Tao, Ze-Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838451/ https://www.ncbi.nlm.nih.gov/pubmed/26351210 http://dx.doi.org/10.3727/096504015X14386062091398 |
Ejemplares similares
-
Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549
por: Soltanian, Sara, et al.
Publicado: (2021) -
Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy
por: Wang, Shuang, et al.
Publicado: (2022) -
The Potent Antitumor Activity of Smp43 against Non-Small-Cell Lung Cancer A549 Cells via Inducing Membranolysis and Mitochondrial Dysfunction
por: Deng, Ze, et al.
Publicado: (2023) -
Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer
por: Matsumoto, Mitsunobu, et al.
Publicado: (2001) -
Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway
por: Tuya, Naren, et al.
Publicado: (2017)